News - BioPharm International

ADVERTISEMENT

News

EMA Recommended 81 Medicines for Marketing Authorization in 2013

January 23, 2014

In 2013, the EMA's Committee for Medicinal Products for Human Use recommended 81 medicines for human use for marketing authorization, compared with 57 in 2012.

Shire Appoints Susan Kilsby as Its New Chairman Effective April 2014

January 23, 2014

Shire appoints Susan Kilsby as its New Chairman.

The Carlyle Group Agrees to Acquire Johnson & Johnson#39;s Ortho-Clinical Diagnostics Business

January 22, 2014

J&J's diagnostics business goes to global asset manager, The Carlyle Group.

Sanofi and Fraunhofer Create Center to Accelerate Antibiotic Research

January 22, 2014

The Natural Product Center of Excellence seeks to identify novel active compounds for new antibiotics.

Teva to Expand Central Nervous System Portfolio with Acquisition of NuPathe

January 22, 2014

Teva announced an agreement to acquire NuPathe and its migraine treatment patch.

Merck Recalls Cholesterol Medicine Due to Packaging Defect

January 16, 2014

A packaging defect has led to Merck voluntarily recalling all lots of Liptruzet tablets in the United States.

USP Announces Revision Timeline, Effective Date for Elemental Impurities Limits and Procedures

January 15, 2014

USP announced the approval of General Notices section 5.60.30 Elemental Impurities in USP Drug Products and Dietary Supplements with an official date of Dec. 1, 2015.

FDA Releases New Guidance on Drug Development Tools

January 9, 2014

FDA releases guidance on the qualification of drug development tools.

MedImmune Signs Cancer Pact with Immunocore

January 9, 2014

MedImmune has entered into a research collaboration with Immunocore to develop novel cancer therapies.

ADVERTISEMENT

ADVERTISEMENT

Click here